Skip to main content

ADC Therapeutics SA S-3, filed Nov 10, 2026

ADC Therapeutics SA (ADCT)

ADC Therapeutics SA registered up to 61,000,000 common shares for resale, covering 12,911,347 shares and 48,088,653 shares issuable from pre-funded warrants sold to institutional investors in the October 7, 2026 private placement. AI summary

S-3 2026-11-10
View Original
Added on November 10, 2026